Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Prostate-specific acid phosphatase immunoreactivity in adenocarcinomas of the urinary bladder.

Epstein JI, Kuhajda FP, Lieberman PH.

Hum Pathol. 1986 Sep;17(9):939-42.

PMID:
2428729
2.

Prostate cancer-associated markers.

Chu TM.

Immunol Ser. 1990;53:339-56. Review.

PMID:
1713065
3.

Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.

Knez VM, Barrow W, Lucia MS, Wilson S, La Rosa FG.

J Med Case Rep. 2014 Aug 14;8:275. doi: 10.1186/1752-1947-8-275. Review.

4.

[A case of synchronous double primary cancers of prostate, and bladder in a hemodialysis patient: a case report].

Abe T, Hayashi T, Nakayama J, Kishikawa H, Sekii K, Yoshioka T, Itatani H, Kojima Y, Takahara S.

Hinyokika Kiyo. 2005 Oct;51(10):689-93. Review. Japanese.

5.

Prostatic acid phosphatase: its current clinical status.

Heller JE.

J Urol. 1987 Jun;137(6):1091-103. Review. No abstract available.

PMID:
3295298
6.

Prostate-specific antigen and prostatic acid phosphatase: biomolecular and physiologic characteristics.

Bilhartz DL, Tindall DJ, Oesterling JE.

Urology. 1991 Aug;38(2):95-102. Review.

PMID:
1715106

Supplemental Content

Support Center